360 related articles for article (PubMed ID: 24532983)
21. The Length of
Corrado L; De Marchi F; Tunesi S; Oggioni GD; Carecchio M; Magistrelli L; Tesei S; Riboldazzi G; Di Fonzo A; Locci C; Trezzi I; Zangaglia R; Cereda C; D'Alfonso S; Magnani C; Comi GP; Bono G; Pacchetti C; Cantello R; Goldwurm S; Comi C
Front Neurol; 2018; 9():213. PubMed ID: 29662465
[TBL] [Abstract][Full Text] [Related]
22. Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease.
Lasser-Katz E; Simchovitz A; Chiu WH; Oertel WH; Sharon R; Soreq H; Roeper J; Goldberg JA
J Neurosci; 2017 Jan; 37(1):47-57. PubMed ID: 28053029
[TBL] [Abstract][Full Text] [Related]
23.
Li W; Fu Y; Halliday GM; Sue CM
Front Cell Dev Biol; 2021; 9():612476. PubMed ID: 34295884
[TBL] [Abstract][Full Text] [Related]
24. Generation of SNCA Cell Models Using Zinc Finger Nuclease (ZFN) Technology for Efficient High-Throughput Drug Screening.
Dansithong W; Paul S; Scoles DR; Pulst SM; Huynh DP
PLoS One; 2015; 10(8):e0136930. PubMed ID: 26317803
[TBL] [Abstract][Full Text] [Related]
25. Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease.
Yonova-Doing E; Atadzhanov M; Quadri M; Kelly P; Shawa N; Musonda ST; Simons EJ; Breedveld GJ; Oostra BA; Bonifati V
Parkinsonism Relat Disord; 2012 Jun; 18(5):567-71. PubMed ID: 22445250
[TBL] [Abstract][Full Text] [Related]
26. The central theme of Parkinson's disease: α-synuclein.
Ozansoy M; Başak AN
Mol Neurobiol; 2013 Apr; 47(2):460-5. PubMed ID: 23180276
[TBL] [Abstract][Full Text] [Related]
27. Upregulated ECM genes and increased synaptic activity in Parkinson's human DA neurons with PINK1/ PRKN mutations.
Tripathi U; Rosh I; Ben Ezer R; Nayak R; Hussein Y; Choudhary A; Djamus J; Manole A; Houlden H; Gage FH; Stern S
NPJ Parkinsons Dis; 2024 May; 10(1):103. PubMed ID: 38762512
[TBL] [Abstract][Full Text] [Related]
28. Analysis of the genetic variability in Parkinson's disease from Southern Spain.
Bandrés-Ciga S; Mencacci NE; Durán R; Barrero FJ; Escamilla-Sevilla F; Morgan S; Hehir J; Vives F; Hardy J; Pittman AM
Neurobiol Aging; 2016 Jan; 37():210.e1-210.e5. PubMed ID: 26518746
[TBL] [Abstract][Full Text] [Related]
29. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.
Taguchi T; Ikuno M; Hondo M; Parajuli LK; Taguchi K; Ueda J; Sawamura M; Okuda S; Nakanishi E; Hara J; Uemura N; Hatanaka Y; Ayaki T; Matsuzawa S; Tanaka M; El-Agnaf OMA; Koike M; Yanagisawa M; Uemura MT; Yamakado H; Takahashi R
Brain; 2020 Jan; 143(1):249-265. PubMed ID: 31816026
[TBL] [Abstract][Full Text] [Related]
30. Glutathione
Jewett M; Dickson E; Brolin K; Negrini M; Jimenez-Ferrer I; Swanberg M
Front Neurol; 2018; 9():222. PubMed ID: 29681884
[TBL] [Abstract][Full Text] [Related]
31. Genetic Imaging of Neuroinflammation in Parkinson's Disease: Recent Advancements.
Yao L; Wu J; Koc S; Lu G
Front Cell Dev Biol; 2021; 9():655819. PubMed ID: 34336822
[TBL] [Abstract][Full Text] [Related]
32. Genetics of Parkinson's disease: a review of SNCA and LRRK2.
Konno T; Siuda J; Wszolek ZK
Wiad Lek; 2016; 69(3 Pt 1):328-32. PubMed ID: 27486710
[TBL] [Abstract][Full Text] [Related]
33. Parkinson's disease: the genetics of a heterogeneous disorder.
Gosal D; Ross OA; Toft M
Eur J Neurol; 2006 Jun; 13(6):616-27. PubMed ID: 16796586
[TBL] [Abstract][Full Text] [Related]
34. Genetic assessment of familial and early-onset Parkinson's disease in a Greek population.
Bozi M; Papadimitriou D; Antonellou R; Moraitou M; Maniati M; Vassilatis DK; Papageorgiou SG; Leonardos A; Tagaris G; Malamis G; Theofilopoulos D; Kamakari S; Stamboulis E; Hadjigeorgiou GM; Athanassiadou A; Michelakakis H; Papadimitriou A; Gasser T; Stefanis L
Eur J Neurol; 2014 Jul; 21(7):963-8. PubMed ID: 24313877
[TBL] [Abstract][Full Text] [Related]
35. Hypomethylation of SNCA in blood of patients with sporadic Parkinson's disease.
Ai SX; Xu Q; Hu YC; Song CY; Guo JF; Shen L; Wang CR; Yu RL; Yan XX; Tang BS
J Neurol Sci; 2014 Feb; 337(1-2):123-8. PubMed ID: 24326201
[TBL] [Abstract][Full Text] [Related]
36. The SNCA-Rep1 Polymorphic Locus: Association with the Risk of Parkinson's Disease and SNCA Gene Methylation.
Iakovenko EV; Abramycheva NY; Fedotova EY; Illarioshkin SN
Acta Naturae; 2020; 12(2):105-110. PubMed ID: 32742734
[TBL] [Abstract][Full Text] [Related]
37. Dysfunction of Synaptic Vesicle Endocytosis in Parkinson's Disease.
Zou L; Tian Y; Zhang Z
Front Integr Neurosci; 2021; 15():619160. PubMed ID: 34093144
[TBL] [Abstract][Full Text] [Related]
38. Variant in the 3' region of SNCA associated with Parkinson's disease and serum α-synuclein levels.
Hu Y; Tang B; Guo J; Wu X; Sun Q; Shi C; Hu L; Wang C; Wang L; Tan L; Shen L; Yan X; Zhang H
J Neurol; 2012 Mar; 259(3):497-504. PubMed ID: 21853288
[TBL] [Abstract][Full Text] [Related]
39. Parkin mutation decreases neurite complexity and maturation in neurons derived from human fibroblasts.
Pu J; Gao T; Zheng R; Fang Y; Ruan Y; Jin C; Shen T; Tian J; Zhang B
Brain Res Bull; 2020 Jun; 159():9-15. PubMed ID: 32156628
[TBL] [Abstract][Full Text] [Related]
40. Progress in the pathogenesis and genetics of Parkinson's disease.
Mizuno Y; Hattori N; Kubo S; Sato S; Nishioka K; Hatano T; Tomiyama H; Funayama M; Machida Y; Mochizuki H
Philos Trans R Soc Lond B Biol Sci; 2008 Jun; 363(1500):2215-27. PubMed ID: 18426756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
